Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies

Documenti analoghi

• Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
  di: Mizoguchi, Takanori, et al.
  Pubblicazione: (2017)
• Clinical Experience of Using 0.2 % Olopatadin in the Allergic Conjunctivitis Treatment
  di: S. V. Yanchenko, et al.
  Pubblicazione: (2019-10-01)
• Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle‐controlled study
  di: Liu, Rui‐fen, et al.
  Pubblicazione: (2016)
• Double-masked, randomized, parallel-group study comparing olopatadine 0.1% ophthalmic solution with cromolyn sodium 2% and levocabastine 0.05% ophthalmic preparations in children with seasonal allergic conjunctivitis
  di: Ciprandi, Giorgio, et al.
  Pubblicazione: (2004)
• Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
  di: Ayyappanavar, Shruti, et al.
  Pubblicazione: (2021)